SMYD3 and prostate carcinoma: Since 15-LOX-1 upregulation is suggested to be involved in the tumorigenesis of prostate cancer, it was also examined whether SMYD3 is required for 15-LOX-1 transcription in the prostate cancer cell line LNCaP.